News

The first-in-human study aims to evaluate the safety and feasibility of a novel real-time catheter-based system to detect microvascular obstruction immediately after primary percutaneous coronary intervention (PPCI) and deliver timely...

The coraCatheters family of novel devices is the latest in the Reflow portfolio, which includes the Wingman™ and Spex™ Catheters.

Corazon, Inc. announced a formal partnership with the Society for Cardiovascular Angiography & Interventions (SCAI), the only professional medical society in the U.S. dedicated solely to interventional cardiology.

A new study using data from millions of patients hospitalized across the United States has determined whether population density and associated urban vs. suburban vs. rural environments predispose patients with peripheral vascular disease for...

In the document, the writing group suggests updated practical algorithmic approaches to in-stent restenosis and stent thrombosis.

SCAI President Sunil V. Rao, MD, FSCAI recognized outstanding SCAI members for their ongoing contributions to the field of interventional cardiology, the Society, and patient care.

Results found marijuana users are at a significantly increased risk of developing PAD, compared to the general population.

The study demonstrated the safety and efficacy of a newly designed longer length stent designed to perform percutaneous coronary interventions (PCI) for patients with diffuse coronary artery disease (CAD).

The initial results demonstrated that Supira Medical’s low profile, high continuous flow device allowed for successful procedure completion for patients undergoing high-risk percutaneous coronary interventions (PCI).

The single-center, randomized-controlled trial evaluated outcomes of hand function and effectiveness of conventional proximal radial artery (PRA) access compared to distal radial artery (DRA) access for cardiac catheterization.